These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3818082)

  • 1. Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide.
    Repo H; Leirisalo-Repo M; Nurminen M; Mäkelä PH
    Infect Immun; 1987 Mar; 55(3):507-12. PubMed ID: 3818082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkali-treated LPS of Yersinia enterocolitica does not induce expression of E-selectin, ICAM-1 or VCAM-1 on endothelial cells but may mediate antibody- and complement-dependent cell injury.
    Repo H; Renkonen R; Helander IM; Leirisalo-Repo M
    Scand J Immunol; 1994 Mar; 39(3):241-8. PubMed ID: 7510411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of
    Kasperkiewicz K; Świerzko AS; Przybyła M; Szemraj J; Barski J; Skurnik M; Kałużyński A; Cedzyński M
    J Immunol Res; 2020; 2020():7439506. PubMed ID: 33274243
    [No Abstract]   [Full Text] [Related]  

  • 4. Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis.
    Lahesmaa-Rantala R; Lehtonen OP; Granfors K; Toivanen A
    Arthritis Rheum; 1987 Oct; 30(10):1176-81. PubMed ID: 3675663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common serological features in rheumatoid arthritis and yersinia arthritis. Demonstration of rheumatoid factors and antibodies against ssDNA and Yersinia enterocolitica Lipopolysaccharide by ELISA.
    Gripenberg M
    Scand J Rheumatol; 1981; 10(2):85-91. PubMed ID: 7244583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia lipopolysaccharide is modified by human monocytes.
    Wuorela M; Jalkanen S; Toivanen P; Granfors K
    Infect Immun; 1993 Dec; 61(12):5261-70. PubMed ID: 7693597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of Reiter's syndrome, with special emphasis on Yersinia enterocolitica.
    Yu DT; Ogasawara M; Hill JL; Kono DH
    Immunol Rev; 1985 Aug; 86():27-45. PubMed ID: 3876266
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.
    Granfors K; Merilahti-Palo R; Luukkainen R; Möttönen T; Lahesmaa R; Probst P; Märker-Hermann E; Toivanen P
    Arthritis Rheum; 1998 May; 41(5):855-62. PubMed ID: 9588737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin IgG subclass distribution of antibody responses to Yop proteins and lipopolysaccharide of Yersinia enterocolitica in patients with yersiniosis.
    Rastawicki W; Jakubczak A
    Pol J Microbiol; 2007; 56(4):233-8. PubMed ID: 18254492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response.
    Mertz AK; Ugrinovic S; Lauster R; Wu P; Grolms M; Böttcher U; Appel H; Yin Z; Schiltz E; Batsford S; Schauer-Petrowski C; Braun J; Distler A; Sieper J
    Arthritis Rheum; 1998 Feb; 41(2):315-26. PubMed ID: 9485090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS; Edgington TS
    J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide exposure during purification of human monocytes by adherence increases their recovery and cytolytic activity.
    Chen AR; Whitaker FS; McKinnon KP; Koren HS
    Cell Immunol; 1986 Nov; 103(1):120-32. PubMed ID: 3802206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.
    Granfors K; Jalkanen S; von Essen R; Lahesmaa-Rantala R; Isomäki O; Pekkola-Heino K; Merilahti-Palo R; Saario R; Isomäki H; Toivanen A
    N Engl J Med; 1989 Jan; 320(4):216-21. PubMed ID: 2643047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
    Rastawicki W
    Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of circulating Yersinia-specific immune complexes in patients with yersiniosis.
    Lahesmaa-Rantala R; Granfors K; Lehtonen OP; Toivanen A
    Clin Immunol Immunopathol; 1987 Feb; 42(2):202-10. PubMed ID: 2948750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response against 26 and 46 kilodalton released proteins of yersinia in yersinia triggered reactive arthritis.
    Mäki-Ikola O; Pulz M; Heesemann J; Lahesmaa R; Saario R; Toivanen A; Granfors K
    Ann Rheum Dis; 1992 Nov; 51(11):1247-9. PubMed ID: 1466603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study.
    Dalby T; Rasmussen E; Schiellerup P; Krogfelt KA
    BMC Microbiol; 2017 May; 17(1):125. PubMed ID: 28545413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of complement activity in vitro and in vivo by Yersinia wild and mutant strains.
    Yordanov M; Golkocheva E; Najdenski H
    Folia Microbiol (Praha); 2006; 51(1):27-32. PubMed ID: 16821708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.